Fact CheckerSign in

NCT06679985Active, not recruitingPhase 2

A Trial of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma

A Randomized Phase 2 Study of Casdozokitug in Combination With Toripalimab Plus Bevacizumab in Participants With Unresectable and/or Locally Advanced or Metastatic Hepatocellular Carcinoma

Source: ClinicalTrials.gov · Last updated 15 Jul 2026

Brief summary (registry, in English)

The main goals of this study are to evaluate the safety and efficacy of casdozokitug in combination with toripalimab plus bevacizumab and to define a recommended dose for casdozokitug in combination with toripalimab plus bevacizumab.

Status (registry)
Active, not recruiting
Phase (registry)
Phase 2
Study type
Interventional
Enrollment
72 (estimated)
First submitted
6 Nov 2024
Start date
20 Dec 2024
Primary completion date
Sept 2027
Lead sponsor
Coherus Oncology, Inc.
NCT number
NCT06679985

What you commit to

  • Study type: Interventional · Phase 2
  • Planned participants: 72
  • From 20 Dec 2024 to the primary completion date, Sept 2027
  • 44 sites in 6 countries
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Prior treatment

  • Has received prior systemic therapy for HCC.
  • Has previously received an anti-IL-27 antibody (Ab) or anti-IL-27-targeted therapy.

Other

  • Has known fibrolamellar HCC histology, sarcomatoid HCC, or mixed cholangiocarcinoma and HCC.
  • Has moderate or severe ascites.
  • Has uncontrolled pleural effusion, pericardial effusion, or ascites requiring recurrent drainage procedures (once monthly or more frequently).
    • Additional protocol-defined inclusion/exclusion criteria apply.

Who the study is looking for

  • Unresectable locally advanced or metastatic HCC with diagnosis confirmed by histology/cytology or clinically by American Association for the Study of Liver Diseases criteria in cirrhotic participants.
  • Disease that is not amenable to curative surgical and/or locoregional therapies or progressive disease (PD) after surgical and/or locoregional therapies.
  • ≥ 1 measurable lesion (per RECIST v1.1) that is untreated.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (44)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Bankstown-Lidcombe Hospital
Coordinator of this site? Confirm its status
BankstownAustraliaUnknown status
St Vincent's Hospital Sydney
Coordinator of this site? Confirm its status
DarlinghurstAustraliaUnknown status
Royal Brisbane and Women's Hospital
Coordinator of this site? Confirm its status
HerstonAustraliaUnknown status
Monash Health
Coordinator of this site? Confirm its status
MelbourneAustraliaUnknown status
Linear Clinical Research
Coordinator of this site? Confirm its status
NedlandsAustraliaUnknown status
Sunnybrook Health Sciences Centre - Bayview Campus
Coordinator of this site? Confirm its status
TorontoCanadaUnknown status
Princess Margaret Hospital
Coordinator of this site? Confirm its status
TorontoCanadaUnknown status
Humanity & Health Clinical Trial Centre
Coordinator of this site? Confirm its status
Hong KongHong Kong SAR ChinaUnknown status
Queen Mary Hospital
Coordinator of this site? Confirm its status
Hong KongHong Kong SAR ChinaUnknown status
Prince of Wales Hospital
Coordinator of this site? Confirm its status
ShatinHong Kong SAR ChinaUnknown status
Curie Oncology
Coordinator of this site? Confirm its status
SingaporeSingaporeUnknown status
Tan Tock Seng Hospital
Coordinator of this site? Confirm its status
SingaporeSingaporeUnknown status
National Cancer Centre Singapore
Coordinator of this site? Confirm its status
SingaporeSingaporeUnknown status
China Medical University Hospital
Coordinator of this site? Confirm its status
TaichungTaiwanUnknown status
Chi Mei Medical Center
Coordinator of this site? Confirm its status
TainanTaiwanUnknown status
National Cheng Kung University Hospital
Coordinator of this site? Confirm its status
TainanTaiwanUnknown status
National Taiwan University Hospital
Coordinator of this site? Confirm its status
TainanTaiwanUnknown status
Taipei Veterans General Hospital
Coordinator of this site? Confirm its status
TaipeiTaiwanUnknown status
Linkou Chang Gung Memorial Hospital (CGMHLK)
Coordinator of this site? Confirm its status
Taoyuan CityTaiwanUnknown status
The Winship Cancer Institute Emory University
Coordinator of this site? Confirm its status
AtlantaUnited StatesUnknown status
Beverly Hills Cancer Center
Coordinator of this site? Confirm its status
Beverly HillsUnited StatesUnknown status
Mountain States Tumor Institute at St. Luke's Regional Medical Center
Coordinator of this site? Confirm its status
BoiseUnited StatesUnknown status
University of North Carolina (UNC) - Chapel Hill
Coordinator of this site? Confirm its status
Chapel HillUnited StatesUnknown status
University Hospitals Cleveland Medical Center*
Coordinator of this site? Confirm its status
ClevelandUnited StatesUnknown status
The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solovev Research Institute (OSUCCC - James)
Coordinator of this site? Confirm its status
ColumbusUnited StatesUnknown status
City of Hope
Coordinator of this site? Confirm its status
DuarteUnited StatesUnknown status
Virginia Cancer Specialists
Coordinator of this site? Confirm its status
FairfaxUnited StatesUnknown status
Prisma Health Cancer Institute
Coordinator of this site? Confirm its status
GreenvilleUnited StatesUnknown status
City of Hope at Irvine Lennar
Coordinator of this site? Confirm its status
IrvineUnited StatesUnknown status
University of Mississippi Medical Center
Coordinator of this site? Confirm its status
JacksonUnited StatesUnknown status
Mayo Clinic- Jacksonville
Coordinator of this site? Confirm its status
JacksonvilleUnited StatesUnknown status
University of Kansas Cancer Center
Coordinator of this site? Confirm its status
Kansas CityUnited StatesUnknown status
Cancer & Blood Specialty Clinic
Coordinator of this site? Confirm its status
LakewoodUnited StatesUnknown status
USC / Norris Comprehensive Cancer Center
Coordinator of this site? Confirm its status
Los AngelesUnited StatesUnknown status
UofL Health Brown Cancer Center
Coordinator of this site? Confirm its status
LouisvilleUnited StatesUnknown status
UW Carbone Cancer Center - Cancer Connect
Coordinator of this site? Confirm its status
MadisonUnited StatesUnknown status
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center
Coordinator of this site? Confirm its status
New YorkUnited StatesUnknown status
Virginia Oncology Associates
Coordinator of this site? Confirm its status
NorfolkUnited StatesUnknown status
University of Pittsburgh Medical Center (UPMC) - Hillman Cancer Center
Coordinator of this site? Confirm its status
PittsburghUnited StatesUnknown status
Christus St. Vincent Regional Medical Center
Coordinator of this site? Confirm its status
Santa FeUnited StatesUnknown status
Sarcoma Oncology Center
Coordinator of this site? Confirm its status
Santa MonicaUnited StatesUnknown status
Mayo Clinic Scottsdale
Coordinator of this site? Confirm its status
ScottsdaleUnited StatesUnknown status
Montefiore Medical Center
Coordinator of this site? Confirm its status
The BronxUnited StatesUnknown status
University of Arizona Cancer Center
Coordinator of this site? Confirm its status
TucsonUnited StatesUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.